Adam Jasne, MD
Associate Professor TermCards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileContact Info
About
Titles
Associate Professor Term
Biography
Dr. Jasne completed his residency training at the University of Maryland Medical Center and his fellowship at the University of Cincinnati. His research interests include stroke epidemiology, access to quality care, and uncommon neuroimaging findings. He joined the faculty at Yale in 2018, where he treats patients with a variety of cerebrovascular disorders in inpatient and outpatient settings. He is board certified in Neurology and Vascular Neurology.
Appointments
Neurology
Associate Professor on TermPrimary
Other Departments & Organizations
Education & Training
- Fellow
- University of Cincinnati (2018)
- Resident
- University of Maryland Medical Center (2016)
- MD
- Ohio State University College of Medicine (2012)
- BS
- Carnegie Mellon University, Cognitive Science and French
Research
Overview
Medical Research Interests
Public Health Interests
ORCID
0000-0001-9092-3607
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Lauren Hachmann Sansing, MD, MS, FAHA, FANA
Joseph Schindler, MD
Charles Wira, MD
Guido J. Falcone, MD, ScD, MPH
Charles Matouk, MD
Kevin Sheth, MD
Publications
Featured Publications
Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic
Sharma R, Kuohn LR, Weinberger DM, Warren JL, Sansing LH, Jasne A, Falcone G, Dhand A, Sheth KN. Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic. Stroke 2021, 52: 563-572. PMID: 33430638, PMCID: PMC7834664, DOI: 10.1161/strokeaha.120.031975.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsEmergency medical servicesCerebrovascular deathCOVID-19 deathsCerebrovascular mortalityCOVID-19 pandemicStroke-related deathCoronavirus disease 2019 (COVID-19) pandemicFirst COVID-19 deathDisease 2019 pandemicPublic health measuresHealth Statistics dataPoisson regression modelsCumulative COVID-19 deathsAcute strokeStroke deathsVascular pathologyEMS callsMedical careHealth measuresNew York CityMortalityDeathMedical servicesWeeksRegression analysisCerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted diffusion (CHANTER) Syndrome
Jasne AS, Alsherbini KH, Smith MS, Pandhi A, Vagal A, Kanter D. Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted diffusion (CHANTER) Syndrome. Neurocritical Care 2019, 31: 288-296. PMID: 30788708, PMCID: PMC6757017, DOI: 10.1007/s12028-018-00666-4.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdultAlcoholic IntoxicationAmphetaminesBasal GangliaBenzodiazepinesBrain EdemaCentral Nervous System StimulantsCerebellar CortexCerebellumCocaineComaFemaleHeroinHippocampusHumansHydrocephalusHydromorphoneMagnetic Resonance ImagingMaleMiddle AgedOpiate AlkaloidsPain, PostoperativeStuporSubstance-Related DisordersSyndromeConceptsCerebellar edemaIschemic strokeObstructive hydrocephalusCerebellar cortexAcute cytotoxic edemaSeries of patientsNeurocritical care unitPatterns of injuryLevel of consciousnessMagnetic resonance imagingClinical characteristicsInitial presentationCare unitSurgical managementHypoxic injuryCytotoxic edemaFavorable outcomeSimilar presentationAnoxic injuryBilateral hippocampusTransient edemaBasal nucleusToxic injuryNovel syndromeAcceptable outcomesStroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic
Jasne AS, Chojecka P, Maran I, Mageid R, Eldokmak M, Zhang Q, Nystrom K, Vlieks K, Askenase M, Petersen N, Falcone GJ, Wira CR, Lleva P, Zeevi N, Narula R, Amin H, Navaratnam D, Loomis C, Hwang DY, Schindler J, Hebert R, Matouk C, Krumholz HM, Spudich S, Sheth KN, Sansing LH, Sharma R. Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic. Stroke 2020, 51: 2664-2673. PMID: 32755347, PMCID: PMC7446978, DOI: 10.1161/str.0000000000000347.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAgedAged, 80 and overBetacoronavirusBrain IschemiaCohort StudiesComorbidityConnecticutCoronary Artery DiseaseCoronavirus InfectionsCOVID-19DyslipidemiasEmergency Medical ServicesEthnicityFemaleHumansHypertensionIncomeInsurance, HealthIntracranial HemorrhagesMaleMedically UninsuredMiddle AgedOutcome and Process Assessment, Health CarePandemicsPneumonia, ViralRetrospective StudiesSARS-CoV-2Severity of Illness IndexStrokeSubstance-Related DisordersTelemedicineThrombectomyThrombolytic TherapyTime-to-TreatmentConceptsComprehensive stroke centerStroke codePatient characteristicsStroke severityStroke code patientsHistory of hypertensionStroke-like symptomsCoronary artery diseaseCoronavirus disease 2019 (COVID-19) pandemicPatient-level dataLower median household incomePublic health initiativesDisease 2019 pandemicCOVID-19 pandemicRace/ethnicityCode patientsHospital presentationPublic health insuranceRankin ScaleStroke centersArtery diseaseReperfusion timeStroke symptomsEarly outcomesConnecticut hospitals
2025
Differences in In-Hospital and Post-Discharge Ischemic Stroke Care According to Prestroke Functional Status.
Wechsler P, Mistry E, Sucharew H, Robinson D, Stanton R, de Los Rios La Rosa F, Mackey J, Ferioli S, Demel S, Coleman E, Jasne A, Slavin S, Walsh K, Star M, Haverbusch M, Alwell K, Woo D, Kleindorfer D, Kissela B. Differences in In-Hospital and Post-Discharge Ischemic Stroke Care According to Prestroke Functional Status. Journal Of The American Heart Association 2025, 14: e040499. PMID: 40417811, DOI: 10.1161/jaha.124.040499.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsIschemic stroke carePrestroke disabilityStroke careIn-hospitalGreater Cincinnati/Northern Kentucky populationAssociated with lower oddsPopulation-based dataSecondary stroke prevention treatmentPrestroke functional statusMedical decision-makingCare continuumStroke prevention treatmentRehabilitation therapyLower oddsIschemic stroke patientsFunctional statusStroke reperfusion therapyStroke patientsLogistic regressionCareDisabilityKentucky populationAcute ischemic strokeReperfusion therapyPrestrokeImpact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing Thrombectomy
Fladt J, Benali F, Jaroenngarmsamer T, Bala F, Singh N, Nogueira R, McTaggart R, Demchuk A, Poppe A, Buck B, Tymianski M, Hill M, Goyal M, Ganesh A, Barber P, Smith E, Bal S, Subramanian S, Peters S, Couillard P, Klein G, Stys P, Coutts S, Wong J, Mitha A, Eesa M, Morrish W, Alqatani S, Alqatani S, Venkatesan P, Teleg E, Sitaram A, Graham B, van Gaal S, Moussaddy A, Chakraborty D, Maraj N, Lockey A, Chen S, Singh R, Alsultan A, Asunsian R, Tse D, Doshi D, Volny O, Ojha P, Wadhwa A, Marko M, Singh N, Wasyliw S, Ryckborst K, Kenney C, Save S, Jambula A, Newcommon N, Hull G, Blackstock D, Kiszczak S, Zimmel L, Wright M, Jahraus C, Andersen L, Bohn S, Paul J, Buck B, Butcher K, Shuaib A, Jeerakathil T, Jickling G, Emery D, Rempel J, Ower R, Ashforth R, Yeo T, Kotylak T, O'Kelly C, Chow M, Siddiqui M, Saqqur M, D'Souza A, Lloret M, Butt A, Nomani A, Kalashyan H, Thirunavukkarasu S, Jabs J, Fairall P, Piquette L, Phillips S, Green A, Gubitz G, Heidenreich J, Huynh T, Shankar J, Maloney W, Vandorpe R, Schmidt M, Pickett G, Weeks A, Jarrett J, MacDonald D, Arsenault J, Kinnear R, Mandzia J, Mayich M, Boulton M, Bullrich M, Fridman S, Kiwan R, Lee D, Lownie S, Khaw A, Pandey S, Sharma M, Sposato L, Wade K, Beauchamp B, Lambourn L, Amato-Marziali B, Roy D, Deneault N, Deschaintre Y, Gioia L, Jacquin G, Odier C, Stapf C, Iancu D, Raymond J, Weill A, Lapierre M, Jadil N, Jolteus J, Teitelbaum J, Angle M, Hannouche M, Badawy M, Letourneau J, Cortes M, Linnell G, Tampieri D, Vieira L, Moussaddy A, Legault C, Durcan L, Moore A, Cole E, Magnussen C, Salmon K, Khalil S, Desloges I, Waxman L, Abdon W, Lai S, Dowlatshahi D, Iancu D, Shamy M, Stotts G, Blacquiere D, Lesiuk H, Quateen A, Drake B, Dewar B, Daham Z, Kelly M, Hunter G, Peeling L, Graham B, Whelan R, Garner A, Urroz L, Maley S, Silver F, Casaubon L, Pikula A, del Campo M, Schaafsma J, Jaigobin C, Krings T, Pereira V, Agid R, Farb R, Kalman L, Cayley A, Williams J, Stewart T, Misquitta K, Bharatha A, Selchen D, Marotta T, Sarma D, Montanera W, Spears J, Saposnik G, Kostyrko P, Li Y, Parra-Farinas C, Bengzon Diestro J, Camden M, Verreault S, Mackey A, Audet M, Milot G, Lavoie P, Gariepy J, Collard K, Hache A, Sahlas D, Alshanbari A, Baldwin J, Catanese L, Chen B, de Sa Boasquevisque D, Deshmukh A, Knapman J, Lamers S, Larrazabal R, MacMillan S, Mai L, Mattai A, Nayar S, Ng K, Oczkowski W, Perera K, Shawawrah M, Shoamanesh A, Sobhi G, Syed N, Yaher N, Vandervelde C, Wang D, Field T, Van Gaal S, Teal P, Benavente O, Wilson L, Mann S, Yip S, Murphy C, Heran M, Rohr A, Settecase F, Redekop G, Haw C, Maclean G, Murray K, Chiu R, Flexman A, Strecha E, Gayton Y, Yip J, Swartz R, Boulos M, Gladstone D, Yu A, Hopyan J, Khosravani H, Manosalva Alzate H, Southwell A, Kamra M, Lopes K, Kapoor A, da Costa L, Yang V, Dyer E, Shah R, Knowles B, Nichols J, Patterson J, Cope K, Dickerson L, Barton K, Gray K, Massengale T, Miller M, Simpson C, Walker S, Tennyson-Yemm C, Frei D, on R, Atchie B, Kaminsky I, Wilson D, Schraeder N, Arias E, Kodis L, Talley M, Edinger A, Talley T, Dempsey I, Williams L, Williams S, Kupniewski S, Fasbinder B, Snead J, Choe H, Mackenzie L, Weisman D, Kozak O, Shah Q, Gzesh D, Kulandaivel K, Khoury J, Klein B, Bussinger P, Griffin L, DePalmo A, Oliva C, Jadhav A, Jovin T, Kenmuir C, Jankowitz B, Gross B, Rocha M, Starr M, Brown M, Hawkes C, Shah K, Tememe D, Walker G, Patel P, Klein B, Ziayee H, Limaye K, Baxendell L, Glichrist V, Feineigle P, Haibach K, Van Every C, Desai S, Zulfiqar M, Gibson L, Barrett S, Turkel-Parrella D, Arcot K, DiCrescento S, Farkas J, Filipowski G, Frontera J, Joset D, Liff J, Scher E, McDougall C, Kelly C, Patel A, Monteith S, Starkman S, Atchaneeyasakul K, Burgos A, Chua J, Gaines N, Grunberg I, Guzy J, Liu Z, Maluste N, Ramirez L, Sharma L, Heck D, Brown M, McDonald C, Calderon M, Hargis M, Roels C, Emmady P, Alvi T, Jayaraman M, Cutting S, Smith W, Foley S, Paolucci G, Haas R, Quinn K, Fuller L, Brierley R, Watkins C, Demir N, Lopez G, Vargas A, Osteraas N, Holtz B, Sauvageau E, Aghaebrahim A, Chmayssani M, Naval N, Day J, Dellorso S, Ludwig B, Schemmel D, Ebreo N, Bell K, Lewis L, Delucia M, Haussen D, Frankel M, Bhatt N, Bianchi N, Anderson A, Belagaje S, Liberato B, Rangaraju S, Al-Bayati A, Grossber J, Craft L, Schindler K, Schaad E, Schultz M, Sutherly L, Doppelheuer S, Charlton J, Faggard J, Barbret Z, DukSoo Han E, Walters R, Dolia J, El-Jamal S, Eby B, Saleem Y, Pearl H, Patel K, Rahman H, Butt R, English S, Puri A, Howk M, Singh J, Massari F, DeMacedo Rodrigues K, Kuhn A, English J, Barazangi N, Telischak N, Kim W, Ross J, DeVole N, Redford J, Ferreira M, Ponting K, Shen H, Bedenk A, Patel S, Fernandess J, Ke M, Spokoyny I, Gao B, Tong D, Chen C, Wong C, Choe J, Martin C, Summers D, Boutwell C, Olds K, Crandall S, Eatman J, Akhtar N, Holloway W, Halpin J, Donegan B, Schindler J, Hwang D, Gilmore E, Petersen N, Sheth K, Brown S, Beekman R, George B, Kaddouh F, Falcone G, Wira C, Matouk C, Loomis C, Amin H, Stretz H, Narula R, Jasne A, Sansing L, Agarwal T, Jasak S, Fontaine B, King Z, Kouhn L, Orgass H, Leary M, Nye J, Halbert K, Nystrom K, Neuschatz K, Petrucci D, Coppola A, Joyce T, Hou S, Umekubo M, Nakamura C, Ovando R, Zuniga D, Nien Y, Basto F, Arch A, Jong L, Conrad W, Abbott T, Yao J, Caganap S, Jordan J, Teitelbaum G, Darflinger R, Kelly D, Gupta R, Budzik R, Czerniak J, Groezinger K, Hicks W, Kaskar O, Katz B, Loochtan A, Pema P, Rai V, Vora N, Brown A, Goodman D, Danenbergs B, Gossett M, Bang O, Chung J, Jeon P, Kim K, Lim Y, Heo J, Nam H, Kim Y, Park H, Hwang I, Ha W, Choi J, Jeong K, Rha J, Park H, Yoon C, Kim B, Sohn S, Kim C, Yoo J, Hong J, Park H, Kim S, Choi M, Bae H, Lee J, Lee J, Jun G, Jeon S, Campbell B, Mitchell P, Yassi N, Davis S, Donnan G, Parsons M, Yan B, Dowling R, Bush S, Wu T, Shan D, Zhao H, Salvaris P, Alemseged F, Ng F, Williams C, Balabanski A, Santos A, Ng J, McDonald A, Jackson D, Tsoleridis J, Pesavento L, Kleinig T, Drew R, Cranefield J, Scroop R, Cagi L, Harvey J, Waters M, Thornton J, Brennan R, O'Hare A, Power S, Williams D, Boyle K, Moynihan B, Liddy A, Large M, Cullen A, Walsh R, Martin E, Lynch J, McElroy S, Murphy S, Coveney S, Deegan C, Horgan G, Kelly P, Laffan A, Llamas-Osorio Y, Lynch C, Mac Mahon P, Marnane M, McCabe J, Burns P, Tauro S, Cuddy S, Rennie I, Smyth G, Flynn P, Wiggam I, Kerr E, Gordon P, Fearon P, Roberts G, Patterson C, Adams K, Wells B, McFarland M, Moreira T, Sjostrand C, Mazya M, Almqvist H, Wahlgren N, Steinberg A, Cooray C, Eriksson E, Thoren M, Keselman B, Ahmed N, Holmberg A, Axelsson M, Berglund A, Golsari A, Hoppe J, Deb-Chatterji M, Cheng B, Barow E, Schlemm E, Lettow I, Jensen M, Otto D, Jaramillo K, Appelbohm H, Fiehler J, Bester M, Schönfeld M, Brekenfeld C, Holst B, Wortmann G, Koch F, Gerber J, Abramyuk A, Kaiser D, Winzer S, Prakapenia A, Pallesen L, Siepmann T, Barlinn K, Haase K, Sauer A, Psychogios M, Liman J, Brehm A, Maus V, Hollstein N, Reinke A, Neitz G, Schnieder M, Schwarz M, Ibrahim A, Muller J, Meister S, Bäumle B, Chapot R, Pilgram-Pastor S, Wallocha M, Stauder M, Celik E, Stracke P, Muller N, Weber R, Veltkamp R, Nagel S, Ringleb P, Heyse M, Amiri H, Mundiyanapurath S, Chen M, Beyrle E, Beck P, Mohlenbruch M. Impact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing Thrombectomy. Neurology 2025, 104: e213619. PMID: 40294371, DOI: 10.1212/wnl.0000000000213619.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAcute ischemic strokeRepeated-measures analysisNIHSS scoreEndovascular thrombectomyStroke severityBrain frailtyCortical atrophyChronic infarctionAssociated with NIHSS scoreIschemic strokeNoncontrast CT scanFollow-up periodWhite matter hyperintensity burdenMultivariable quantile regressionPost hoc analysisAdmission stroke severityRandomized-controlled trialsClinical presentationESCAPE-NA1Brain dysfunctionCT scanSubcortical atrophyNeurological recoveryHyperintensity burdenAcute phase
2024
Core Measures and Data Collection
Nyström K, Jasne A. Core Measures and Data Collection. 2024, 155-165. DOI: 10.1007/978-3-031-66289-8_15.Peer-Reviewed Original ResearchStroke and COVID
Picagli J, Lee K, Jasne A. Stroke and COVID. 2024, 271-278. DOI: 10.1007/978-3-031-66289-8_24.Peer-Reviewed Original ResearchConceptsAdjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
Adeoye O, Broderick J, Derdeyn C, Grotta J, Barsan W, Bentho O, Berry S, Concha M, Davis I, Demel S, Elm J, Gentile N, Graves T, Hoffman M, Huang J, Ingles J, Janis S, Jasne A, Khatri P, Levine S, Majjhoo A, Panagos P, Pancioli A, Pizzella S, Ranasinghe T, Sabagha N, Sivakumar S, Streib C, Vagal A, Wilson A, Wintermark M, Yoo A, Barreto A. Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke. New England Journal Of Medicine 2024, 391: 810-820. PMID: 39231343, PMCID: PMC11528349, DOI: 10.1056/nejmoa2314779.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdultAgedAnticoagulantsArginineCombined Modality TherapyDrug Therapy, CombinationEptifibatideFemaleFibrinolytic AgentsHumansIncidenceInfusions, IntravenousIntracranial HemorrhagesIschemic StrokeMaleMiddle AgedPeptidesPipecolic AcidsPlatelet Aggregation InhibitorsSingle-Blind MethodSulfonamidesThrombectomyThrombolytic TherapyTreatment OutcomeConceptsSymptomatic intracranial hemorrhageIntravenous argatrobanIntravenous thrombolysisAcute ischemic strokeIntracranial hemorrhageIschemic strokeIncidence of symptomatic intracranial hemorrhageSymptom onsetIschemic stroke treated with intravenous thrombolysisAcute ischemic stroke treated with intravenous thrombolysisStroke treated with intravenous thrombolysisAssociated with increased mortalityRankin Scale scoreInitiation of thrombolysisControlled clinical trialsTreatment of acute ischemic strokePlacebo groupEptifibatide groupEfficacy outcomesArgatroban groupStandard treatmentAdjunctive treatmentPlaceboClinical trialsArgatrobanTemporal Trends and Racial Disparities in Long-Term Survival After Stroke
Robinson D, Ding L, Howard G, Stanton R, Khoury J, Sucharew H, Haverbusch M, Nobel L, Khatri P, Adeoye O, Broderick J, Ferioli S, Mackey J, Woo D, Rios La Rosa F, Flaherty M, Slavin S, Star M, Martini S, Demel S, Walsh K, Coleman E, Jasne A, Mistry E, Kleindorfer D, Kissela B. Temporal Trends and Racial Disparities in Long-Term Survival After Stroke. Neurology 2024, 103: e209653. PMID: 39008784, PMCID: PMC11249510, DOI: 10.1212/wnl.0000000000209653.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPremorbid functional statusFunctional statusRacial disparitiesAcute ischemic strokeBlack individualsPopulation-based stroke studyBlack raceEffect of black raceNational Death IndexAssociated with 5-year mortalityBaseline functional statusAcute ischemic stroke casesRisk of deathPhysician adjudicationIntracerebral hemorrhageDeath IndexIntracerebral hemorrhage casesUS populationICD codesGeneral populationCalendar yearLogistic regressionModified Rankin ScaleStroke StudyMedical recordsProjections of Endovascular Therapy–Eligible Patients With Stroke for the US Population
Mistry E, Khoury J, Kleindorfer D, Kissela B, Alwell K, Jasne A, Ferioli S, La Rosa F, Coleman E, Demel S, Walsh K, Slavin S, Star M, Haverbusch M, Mackey J, Woo D, Aziz Y, Heldner M, Fischer U, Jadhav A, Jovin T, Albers G, Nogueira R, Khatri P. Projections of Endovascular Therapy–Eligible Patients With Stroke for the US Population. Stroke 2024, 55: 2011-2019. PMID: 38934124, DOI: 10.1161/strokeaha.123.045766.Peer-Reviewed Original ResearchCitationsAltmetricConceptsUS populationStudy of stroke incidenceEndovascular thrombectomyNational Institutes of Health Stroke ScalePrevalence of large vessel occlusionHealth Stroke ScaleIschemic strokeEVT-eligible patientsUnited StatesPopulation-basedPrestroke disabilityStroke systemsStroke incidenceYears of ageLarge vessel occlusionEligibility criteriaAcute ischemic strokePost hoc analysisStroke ScaleObservational studyEligibilityAdult patientsTreatment indicationsHospitalized patientsNational Institute
Clinical Trials
Current Trials
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
HIC ID2000031893RoleSub InvestigatorPrimary Completion Date03/07/2028Recruiting ParticipantsGenderBothAge30 years - 80 yearsRegulating Blood Pressure During Recovery from Intracerebral Hemorrhage and Ischemic Stroke (REDUCE)
HIC ID2000029811RoleSub InvestigatorPrimary Completion Date01/31/2025Recruiting ParticipantsGenderBothAge18+ yearsAnticoagulation for Stroke Prevention and Recovery After ICH (ASPIRE)
HIC ID2000026409RoleSub InvestigatorPrimary Completion Date04/30/2028Recruiting ParticipantsGenderBothAge18+ years
Clinical Care
Overview
Adam Jasne, MD, is a vascular neurologist who primarily treats problems related to blood flow to the brain. This includes ischemic strokes, which are most often caused by blocked arteries, as well as hemorrhagic or bleeding strokes.
Dr. Jasne’s path to medicine was indirect, working in fields including information technology and mental health before he enrolled in medical school. “I was drawn to neurology because I was fascinated by the brain,” he says. “Vascular neurology in particular is an opportunity to help patients in an acute, scary situation, and to continue to work with them in their recovery.”
He also considers it a privilege to be able to help patients and their families through all stages of stroke care—including acute treatment, inpatient hospitalization, and outpatient recovery—as well as to help in situations of disability or end-of-life care.
Establishing good relationships with patients and families is key with conditions like acute stroke, Dr. Jasne explains. “It's important to validate any concerns people have,” he says. “I’ll walk them through how we can care for them, and hopefully make the situation feel more manageable. I share medical information in a way that is understandable—and hopefully approachable and actionable—so that they can take control of their health.”
An assistant professor of neurology at Yale School of Medicine, Dr. Jasne has research interests in quality of care; access to and disparities in stroke care; and unusual non-stroke neuroimaging findings, including a recently recognized condition called CHANTER (cerebellar hippocampal and basal nuclei transient edema with restricted diffusion) syndrome and the opiate-associated Amnestic syndrome, a disorder characterized by impairment in short- and long-term memory.
Clinical Specialties
Fact Sheets
Ischemic Stroke
Learn More on Yale MedicineDizziness
Learn More on Yale MedicineStroke
Learn More on Yale MedicineBlood Clots in Veins, Heart and Lungs
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileGet In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.